BioNTech SE (BNTX) Monday announced a sharp fall in third-quarter earnings compared to the prior year, as the commercial revenues were down sharply. The company revised down its COVID-19 vaccine revenues for the full year 2023.
from RTT - Earnings https://ift.tt/uTE3tQv
via IFTTT
No comments:
Post a Comment